Michael Ackermann

Chairman, Oyster Point Pharmaceuticals, Inc.; Chairman, Tarsus Pharmaceuticals, Inc.; CEO, Presidio Medical, Inc.

Bobby Azamian, MD, PhD

CEO, Tarusus Pharmaceuticals

Juliet Bakker

Managing Partner & Founder, Longitude Capital

John Berdahl, MD

CEO, Equinox; Ophthalmologist, Vance Thompson Vision

Jan Bonel

Founder and Former CEO, Visiometrics

Joseph Boorady, OD, FAAO

VP, Ocular Surface Disease, Johnson & Johnson Vision

Ryan Bouchard

VP Medical Devices, Ora, Inc.

Janet Burk

Publisher, Retina Today

Tom Burns

President and CEO, Glaukos

Chris Calcaterra

COO, Glaukos

Matt Chapin

Senior VP, Corporate Development, Ora, Inc.

Steve Charles, MD

Founder, Charles Retina Institute

Andy Corley

Partner, Flying-L Partners

John Deedrick

Co-founder and Managing Director, Fourth Element Capital

Vincent Deramo, MD

Co-founder, ConnectOnCall; Partner, Long Island Vitreoretinal Consultants

Drew Doshier

Principal, Bluestem Capital

Thomas Frinzi

Worldwide President, Surgical, Johnson & Johnson Vision

Michael Fanning

CEO, Vortex Surgical

Bernie Haffey

Founder, Haffey & Co.

Paul Hallen

Global Head Retina & Glaucoma, Alcon

Rick Heinick

Chairman, TearClear

John Hendrick

President, SafeCo, LLC

Malik Kahook, MD

Vice-Chair Translational Research and Chief, Glaucoma Service, University of Colorado Eye Center

Ron Kurtz, MD

CEO, RxSight, Inc.

Mike Lambert, MD

Founder, Retina and Vitreous of Texas; Board Member, LVX System

Keith Lane

Executive Director and Therapeutic Area Head, Ora, Inc.

Matt Larson

President & COO, Equinox

James Mazzo

Global President, Ophthalmic Devices, Carl Zeiss Meditec

Jeffrey Nau, PhD

President & CEO, Oyster Point Pharma

Matt Oerding

Co-Founder and CEO, Treehouse Eyes

Shawn O’Neil

COO, Sight Sciences

Quinton Oswald

Former CEO, Notal Vision

George Ousler

Senior Vice President of Dry Eye, Ora, Inc.

Ram Palanki

Senior VP of Commercial Strategy and Operations, REGENXBIO

Samir Patel, MD

Co-Founder & Former CEO, Ophthotech

Ed Peterson

Global General Manager, Aviana Molecular Technologies

Jane Rady

Sr. VP Corporate Strategy and Business Development, Glaukos

Firas Rahhal, MD

Partner, ExSight Ventures, Sr. Partner, Retina-Vitreous Associates Medical Group

Tushar Ranchod, MD

Founder, Chairman, CTO, BroadSpot Imaging Corp.; Partner, Bay Area Retina

Ramgopal Rao

CEO, LensGen, Inc.

David Robinson

Partner, Protean, LLC

Amarpreet Sawhney, PhD

President & Chairman, Istylla; Chairman, Ocular Therapeutix

Gregg Scheller

CEO, Katalyst Surgical; Chairman, Kogent Surgical

Aron Shapiro

Sr. VP and Chief Commercial Officer, Ora, Inc.

Andrew Stewart

Associate VP, US Commercial Retina, Allergan

Ramin Valian

VP Retina, Surgical & Upstream Marketing, Allergan

Jim Wachtman

Former CEO, TLC Vision

Jeffry Weinhuff

Managing Partner, Visionary Venture Fund

Gary Wörtz, MD

Founder, Omega Ophthalmics; Ophthalmologist, Commonwealth Eye Surgery

Reza Zadno, PhD

President & CEO, Avedro

Bob Zatarain

CEO, Oculus Surgical, Inc.